• Tag Archives health care
  • Ryancare Is Worse Than Obamacare

    Ryancare Is Worse Than Obamacare

    After 7 years, Republicans finally have the chance to fulfill their promise of repealing Obamacare. With Republicans in control of the legislative and executive branches of the federal government, the only thing standing in their way is themselves, apparently a formidable foe.

    Titled The American Health Care Act, the Republican establishment unveiled their plan to repeal and replace the Affordable Care Act, and it was quickly met with controversy among members of their own party.

    For his part, Trump has intervened to threaten any lawmaker who opposes the establishment. “He made it very clear he’s all-in on this legislation,” said Representative Kevin Brady after a rough meeting with the president. It was a central pillar of his election and, arguably, swung the election in his favor (he had one job). He is now using his power to do something very different.

    Senator Rand Paul has chosen to refer to the AHCA as Obamacare-lite. It’s an apt name, as the bill keeps in place the majority of the Obamacare, namely the supposedly popular provisions. These huge compromises have caused Senator Paul and members of the Freedom Caucus to openly oppose the AHCA and with good reason. By picking and choosing the parts of Obamacare they think are politically expedient instead of the full repeal they promised, the GOP’s proposed bill will exaggerate the ACA’s problems instead of fixing them

    How Obamacare Broke Heath Insurance



    To understand the problems with the AHCA, one has to understand some of Obamacare’s main provisions, the reasons they exist, and how they all fit together. The original purpose of the ACA was to provide insurance coverage to those who had preexisting conditions. The first step taken to achieve this goal was simply to prevent insurers from rejecting these people. However, if the ACA’s architects had stopped here, insurers would simply have offered plans to cancer patients, for instance, that had million dollar premiums, and their goal would have gone unaccomplished.

    This potential “loophole” lead to the provision that gave us the community rating system, which forced insurance companies to charge everyone essentially the same price for similar plans, with a small amount of leeway given factors like age. Community ratings brought about their own problems, however. With insurers forced to accept everyone and unable to charge more for preexisting conditions, people would have no reason to buy insurance until they became ill.

    Further spurred by the necessary rise in premiums, healthy people would begin to refrain from buying insurance, forcing premiums to rise more, and so on until the health insurance industry failed entirely. Referring to this sequence of events, free market economists coined the now famous “death spiral” term.

    The death spiral is obviously very bad, and it prompted the most infamous of Obamacare’s features, the individual mandate. The individual mandate created a tax penalty for those who didn’t hold an approved plan for the entire year. By forcing everyone into the health insurance pool, the ACA’s framers hoped to avoid the death spiral, with subsidies and other mechanisms added into the bill to further encourage the purchase of insurance.

    The Death Spiral Happens Anyway

    At this point, the ACA’s architects were pleased with their work. They had thought through the consequences of their legislation more thoroughly than most, after all. However, they failed to consider the same factor which is the ultimate failure of all central planners, their necessary ignorance of market conditions and how best to handle them.

    The individual mandate failed to coerce enough healthy people to purchase insurance in order to cover the newly added ill. As insurance pools have worsened, and increased demand for health care without a subsequent rise in doctors and hospitals has driven prices up, premiums have grown massively. The death spiral is occurring, despite Obamacare’s attempts to prevent it.

    Insurance companies are hemorrhaging money and going out of business. Some areas now have only one supplier, with 16 counties in my own state of Tennessee having no provider at all. The ACA, like all attempts at central planning, is a failure. At best, the individual mandate’s only effect has been a somewhat slower death spiral.

    The AHCA’s Major Blunder

    Obamacare is a clear example of Ludwig von Mises’ famous adage that government interventions necessitate more and more interventions to fix the problems they create. The fact that the ACA’s provisions are all intertwined is also clear. To avoid an even bigger disaster, all of them need to be repealed at once. But for reasons that are very likely political, the Republican establishment has chosen a weak and compromised bill which  keeps the requirements for preexisting conditions and community ratings, but does does away with the individual mandate. In other words, the ACHA removes Obamacare’s funding mechanism, but keeps the requirements that made it necessary in the first place.

    In the individual mandate’s place is a mandatory 30% surcharge, payable to insurance companies, for those who go without coverage for a prolonged period of time and then choose to purchase another plan. This surcharge is wholly insufficient to fulfill its purpose. Whereas the individual mandate punished people for not purchasing insurance, the surcharge punishes people who’ve decided they do want to buy it. It provides people with very little incentive to continue paying their huge premiums while they’re healthy. Insurance providers simply couldn’t survive in such a distorted environment.

    The GOP’s sacrifice of principles for votes will likely result in a loss of both. If the ACHA passes as is, the health insurance market would collapse in an even more rapid death spiral, and this time the Republican party will be on the receiving end of the political blowback.  Indeed, the ACHA’s inevitable failure would create the perfect political environment for a push towards a single payer system. The left will undoubtedly frame the ensuing chaos as to blame deregulation and the free market, when it truly lies in Obamacare and the Republican party’s spinelessness to propose a proper repeal.

    Free Markets are the Solution

    The Republicans should give the American people what they promised, a repeal of every word of Obamacare. A real repeal is only the first step to repairing health care, however. A repeal must be followed with true free market reforms, particularly those recently proposed by Senator Rand Paul. However, as Warren Gibson wrote for FEE in his 2015 article, the ideal solution is a complete separation of the state and the health care industry. Only free markets can provide the cheapest and highest quality health care to the largest amount of people.


    Nathan Keeble

    Nathan Keeble helped start the Campaign to End Civil Asset Forfeiture in Tennessee.

    This article was originally published on FEE.org. Read the original article.


  • US Beats UK in Lives Saved by Health Care

    US Beats UK in Lives Saved by Health Care

    Last night’s CNN duel between Senators Bernie Sanders and Ted Cruz on the future of Obamacare was pretty illuminating for a recent arrival to the United States, with Senator Sanders’ playbook all-too-familiar to those of us from the UK.

    Sanders wants a single-payer socialized healthcare system in the United States, just as we have in Britain. Any objection to that is met with the claim that you are “leaving people to die.” The only alternatives on offer, you would think, are the U.S. system as it exists now, or the UK system.

    Sanders did not once acknowledge that the UK structure, which is free at the point of use, inevitably means rationed care, with a lack of pre-screening. He also failed to acknowledge that lower health spending levels (indeed, even public spending on health is lower in the UK than the United States now) are not the same as efficiency—which is about outputs per input.

    In the face of anecdote after anecdote about those saved by Obamacare and the virtues of a government-run health system, Cruz countered with some anecdotes from the UK showing the consequences of rationed care: a Scottish hospital turning away pregnant women, a woman in Wales waiting eight hours on the floor for an ambulance to arrive after a fall, and a hospital in Essex canceling life-saving cancer treatment because there were no free beds in intensive care.

    He could also have talked about the Mid-Staffs scandal, or a recent documentary showing doctors deciding between saving a cancer patient or a pensioner bleeding to death.

    Anecdotes are powerful in helping to persuade people, and there are good reasons to use them in debates. Yet they are always susceptible to the charge that all health systems have extreme failures. Perhaps more powerfully then, the inadequacies of the UK system show up systematically in the data about how well conditions are dealt with (data from my former colleague Kristian Niemietz’s reports here and here):

    • In the United States, the age-adjusted breast cancer 5-year survival rate is 88.9 percent, compared with just 81.1 percent in the UK
    • The United States leads the world on the equivalent stat for prostate cancer (97.2 per cent) vs. 83.2 percent in the UK
    • Lung cancer: 18.7 percent in the United States vs. 9.6 percent in the UK; bowel cancer: 64.2 percent vs. 56.1 percent
    • Just in case you think I am cherry picking: U.S. survival rates are also better for leukemia, ovarian cancer, stomach cancer, and liver cancer—all of those for which I can find comparisons
    • The age- and sex-standardized 30-day mortality rate for ischaemic stroke is just 3.6 per cent in the United States vs. 9.2 per cent in the UK; for haemorrhagic stroke, the figures are 22 percent vs. 26.5 percent

    I could go on. All of which is to show that your probability of dying from a range of common conditions is much higher in the UK than here. Perhaps that’s why (with no hint of irony) The Guardian’s write-up of a Commonwealth Fund Report suggesting the UK’s health system was “the best in the world” said “the only serious black mark against the NHS was its poor record on keeping people alive.”

    Reprinted from Cato Institute.


    Ryan Bourne

    Ryan Bourne, former head of public policy at IEA, occupies the R. Evan Scharf chair in the Public Understanding of Economics at the Cato Institute. He is a co-author of “The Minimum Wage: silver bullet or poisoned chalice?” and “Smoking out red herrings.”

    This article was originally published on FEE.org. Read the original article.




  • In Health Care, Freedom Is the Only Way Forward

    The winners of this November’s election will have a unique opportunity to improve American healthcare. Neither higher taxes nor increased ObamaCare big government is the answer.

    For guidance, look to the one area of health care where quality has improved and costs (inflation adjusted) have declined – cosmetic surgery. Why? Unlike the rest of the healthcare industry, cosmetic surgery typically is not reimbursed by insurance.

    Consequently, patients choose carefully among alternative providers and weigh their out-of-pocket costs compared to risks and likely benefits. This is a free-market environment in which consumer choice and competition work to deliver high value to customers.

    The operative word is freedom.

    Freedom of choice involves access to new drugs that have passed FDA safety trials and shown positive results in initial clinical trials, but which have not yet been approved by the FDA. The world has been changing in ways that favor early access. This includes accelerating medical innovations, big data analytics, personalized medicine with drugs tailored to your genetic makeup, and patients’ enthusiasm for sharing data and participating in medical advancements.

    Recently, the world changed in a significant way with Right To Try state legislation which permits patients fighting a terminal illness to get access to not-yet-FDA-approved drugs. Freedom is a powerful rallying call and 31 states have now passed Right To Try legislation with sky-high approval ratings by citizens.

    Problems with Right To Try

    Implementation of Right To Try would encounter big problems. But these very problems may set the stage for political support for freedom to make your own decisions about not-yet-approved drugs for a wide scope of illnesses.

    Assuming there won’t be any federal Right To Try legislation signed into law, the states do not have the legal authority to circumvent the FDA. Moreover, drug developers have a major disincentive to participate because, to survive, drug developers need to secure FDA approvals for their new drugs. And circumventing the FDA by providing not-yet-approved drugs to terminally-ill patients could easily slow or prevent FDA approvals.

    The Better Option

    A better solution is Free To Choose Medicine (FTCM). It would solve the dilemma facing politicians who are pulled in one direction by citizens’ demands for more freedom and in the opposite direction by FDA proponents with demands for a highly-controlled process. A clear, brief explanation of FTCM is available on the Internet in the PowerPoint presentation, “Free To Choose Medicine and Right To Try.” It explains how we will all benefit from more freedom of choice.

    FTCM has three components that greatly improve upon Right To Try.

    First, the Free To Choose track (separate from the FDA’s conventional clinical testing track) enables patients and their doctors to make informed decisions about the use of FDA-approved drugs or not-yet-FDA-approved drugs. Patients, under the guidance of their doctors, would learn about initial safety results and up-to-date treatment results of FTCM drugs. FTCM drugs for a wide range of illnesses (not just terminal illnesses addressed by Right To Try) would be available up to seven years before conventional FDA approval.

    Second, FTCM legislation would provide for government oversight of an open-access, Internet-accessible database. It provides up-to-date information for patients and doctors about a FTCM’s drug’s potential benefits and risks before they choose to use it. This is a self-adjusting system wherein more patients use FTCM drugs that work well and vice versa.

    The open-access database would contain treatment results of FTCM patients including their genetic makeup and relevant biomarkers. This database (not part of Right To Try legislation) would reveal subpopulations of patients who do extremely well or poorly with the new drug. Pinpointing such groups of patients is a huge benefit to, not only patients, but to biopharmaceutical researchers working on new breakthroughs in medicine.

    Third, FTCM federal legislation needs to provide a new type of drug approval – Observational Approval – based on treatment results for real-world patients who receive the FTCM drugs. This would motivate drug developers to participate as well as expedite insurance reimbursement for patients.

    Now that more than 60 percent of states have enacted Right To Try legislation with overwhelming public support, we will inevitably see a clash between politicians who support the heavy hand of the FDA regulatory process, and those who favor freedom of choice.

    Source: In Health Care, Freedom Is the Only Way Forward | Foundation for Economic Education